These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 10399906)

  • 1. Use of the combination product ipratropium and albuterol in chronic obstructive pulmonary disease.
    Crouch MA; Raney CR; Davis K
    Arch Intern Med; 1999 Jul; 159(13):1501-2. PubMed ID: 10399906
    [No Abstract]   [Full Text] [Related]  

  • 2. A combination with clinical recommended dosages of salmeterol and ipratropium is not more effective than salmeterol alone in patients with chronic obstructive pulmonary disease.
    Matera MG; Caputi M; Cazzola M
    Respir Med; 1996 Sep; 90(8):497-9. PubMed ID: 8869445
    [No Abstract]   [Full Text] [Related]  

  • 3. Addition of anticholinergic solution prolongs bronchodilator effect of beta 2 agonists in patients with chronic obstructive pulmonary disease.
    Levin DC; Little KS; Laughlin KR; Galbraith JM; Gustman PM; Murphy D; Kram JA; Hardie G; Reuter C; Ostransky D; McFarland K; Petty TL; Silvers W; Rennard SI; Mueller M; Repsher LH; Zuwallack RL; Vale R
    Am J Med; 1996 Jan; 100(1A):40S-48S. PubMed ID: 8610716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bronchodilating effects of combined therapy with clinical dosages of ipratropium bromide and salbutamol for stable COPD.
    Ikeda A; Nishimura K; Izumi T
    Chest; 1996 Jan; 109(1):294. PubMed ID: 8549208
    [No Abstract]   [Full Text] [Related]  

  • 5. Bronchodilating effects of combined therapy with clinical dosages of ipratropium bromide and salbutamol for stable COPD.
    Ingram RH
    Chest; 1996 Jan; 109(1):293. PubMed ID: 8549206
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical physiological data on the bronchodilator effect of Duovent versus salbutamol in chronic obstructive lung disease.
    Marangio E; Pesci A; Mori A; Marchioni M; Bertorelli G
    Respiration; 1986; 50 Suppl 2():165-8. PubMed ID: 2951798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. For COPD a combination of ipratropium bromide and albuterol sulfate is more effective than albuterol base.
    Campbell S
    Arch Intern Med; 1999 Jan; 159(2):156-60. PubMed ID: 9927098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Daily variation in lung function in COPD patients with combined albuterol and ipratropium: results from a 4-week, randomized, crossover study.
    Singh D; Zhu CQ; Sharma S; Church A; Kalberg CJ
    Pulm Pharmacol Ther; 2015 Apr; 31():85-91. PubMed ID: 25197005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacoeconomic evaluation of a combination of ipratropium plus albuterol compared with ipratropium alone and albuterol alone in COPD.
    Friedman M; Serby CW; Menjoge SS; Wilson JD; Hilleman DE; Witek TJ
    Chest; 1999 Mar; 115(3):635-41. PubMed ID: 10084468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nebulized bronchodilators for outpatient management of stable chronic obstructive pulmonary disease.
    Colice GL
    Am J Med; 1996 Jan; 100(1A):11S-18S. PubMed ID: 8610712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhaled salmeterol: a review of its efficacy in chronic obstructive pulmonary disease.
    Jarvis B; Markham A
    Drugs Aging; 2001; 18(6):441-72. PubMed ID: 11419918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The complementary effects of an anticholinergic and sympathicomimetic drug inhalation in patients with severe chronic obstructive lung disease.
    Sergysels R; Schandevyl W; Yernault JC; Hennebert A
    Acta Tuberc Pneumol Belg; 1976; 67(3-4):163-73. PubMed ID: 138353
    [No Abstract]   [Full Text] [Related]  

  • 13. Use of a long-acting inhaled beta2-adrenergic agonist, salmeterol xinafoate, in patients with chronic obstructive pulmonary disease.
    Rennard SI; Anderson W; ZuWallack R; Broughton J; Bailey W; Friedman M; Wisniewski M; Rickard K
    Am J Respir Crit Care Med; 2001 Apr; 163(5):1087-92. PubMed ID: 11316640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of bronchodilator effects of fenoterol/ipratropium bromide and salbutamol in patients with chronic obstructive lung disease.
    Imhof E; Elsasser S; Karrer W; Grossenbacher M; Emmons R; Perruchoud AP
    Respiration; 1993; 60(2):84-8. PubMed ID: 8341859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of the bronchodilating effects of a beta-2 adrenergic agent (albuterol) and an anticholinergic agent (ipratropium bromide), given by aerosol alone or in sequence.
    Easton PA; Jadue C; Dhingra S; Anthonisen NR
    N Engl J Med; 1986 Sep; 315(12):735-9. PubMed ID: 2943994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticholinergic bronchodilators.
    Witek TJ
    Respir Care Clin N Am; 1999 Dec; 5(4):521-36. PubMed ID: 10565879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic conversion of the combination of ipratropium and albuterol to tiotropium in patients with chronic obstructive pulmonary disease.
    Niewoehner DE; Lapidus R; Cote C; Sharafkhaneh A; Plautz M; Johnson P; Kesten S
    Pulm Pharmacol Ther; 2009 Dec; 22(6):587-92. PubMed ID: 19737620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy and safety of inhaled fluticasone propionate/salmeterol and ipratropium/albuterol for the treatment of chronic obstructive pulmonary disease: an eight-week, multicenter, randomized, double-blind, double-dummy, parallel-group study.
    Make B; Hanania NA; ZuWallack R; Kalberg C; Emmett A; Brown CP; Knobil K
    Clin Ther; 2005 May; 27(5):531-42. PubMed ID: 15978302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The combination of ipratropium and albuterol is more effective than either agent alone.
    Petty TL
    Chest; 1995 May; 107(5 Suppl):183S-186S. PubMed ID: 7743824
    [No Abstract]   [Full Text] [Related]  

  • 20. Thermogenic effect of bronchodilators in patients with chronic obstructive pulmonary disease.
    Burdet L; de Muralt B; Schutz Y; Fitting JW
    Thorax; 1997 Feb; 52(2):130-5. PubMed ID: 9059472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.